NumerixS Investment Technologies’s Enanta Pharmaceuticals ENTA Stock Holding History

NumerixS Investment Technologies’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-700	Closed	-$62K	–	1160
2018 Q3	$62K	Buy	+700	New	+$70.1K	0.01%	922
2018 Q1	–	Sell	-4,900	Closed	-$288K	–	1102
2017 Q4	$288K	Buy	4,900 +3,200	+188%	+$160K	0.07%	356
2017 Q3	$80K	Buy	+1,700	New	+$68.3K	0.02%	819
2017 Q1	–	Sell	-1,800	Closed	-$60K	–	1207
2016 Q4	$60K	Buy	+1,800	New	+$51.6K	0.01%	943
2016 Q2	–	Sell	-9,800	Closed	-$288K	–	1137
2016 Q1	$288K	Buy	9,800 +1,300	+15%	+$36.2K	0.03%	660
2015 Q4	$281K	Buy	+8,500	New	+$277K	0.04%	603
2015 Q3	–	Sell	-10,100	Closed	-$454K	–	685
2015 Q2	$454K	Buy	+10,100	New	+$393K	0.06%	397

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

NumerixS Investment Technologies's ENTA Position: Q4 2018 in Review

NumerixS Investment Technologies sold out of Enanta Pharmaceuticals (ENTA) in Q4 2018, closing a stake of 700 shares — an estimated $62K sold.

NumerixS Investment Technologies first reported a position in ENTA in Q2 2015 and held it in 7 quarters. The position peaked at $454K in Q2 2015. 183 funds tracked by Wall St. Rank hold ENTA as of Q4 2018.

NumerixS Investment Technologies reported no remaining Enanta Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
NumerixS Investment Technologies sold 700 Enanta Pharmaceuticals shares in Q4 2018, an estimated $62K.
NumerixS Investment Technologies first reported a position in Enanta Pharmaceuticals in Q2 2015 and held it in 7 quarters.
NumerixS Investment Technologies's Enanta Pharmaceuticals position peaked at $454K in Q2 2015.
183 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2018.

Based on NumerixS Investment Technologies's 13F filing for Q4 2018, filed 12 Feb 2019.